Filter Search


Healthcare and Medical


Location Summary Deadline
Germany The Health Insurance Companies Aim To Conclude Discount Contracts According To § 130a Abs. 8 Sgb V With All Suitable Pharmaceutical Entrepreneurs For The Active Ingredients, Active Ingredient Combinations, Or Dosage Forms, Strengths, Or Finished Medicinal 2026-06-13
Germany The Health Insurance Companies Aim To Conclude Discount Contracts According To § 130a Abs. 8 Sgb V With All Suitable Pharmaceutical Entrepreneurs For The Active Ingredients, Active Ingredient Combinations, Or Dosage Forms, Strengths, Or Finished Medicinal 2026-06-13
Germany Open House Drug Discount Agreements Teriparatide, Atc H05aa02 2026-06-13
Portugal Acquisition Of D.m. Orthopedics - Nailing Under Consignment Regime 2026-06-13
Portugal Shoulder Arthroscopy And Glenohumeral Instability 2026-06-13
Portugal Supply Of Reagents For The Clinical Pathology Laboratory - Hematology (flow Cytometry) 2026-06-13
Portugal Shoulder And Radial Tacicula Arthroplasty 2026-06-13
Germany Openhouse Biological Discount Contracts 202535 Natalizumab (form For Intravenous Application) 2026-06-13
Germany Conclusion Not Excluding The Discount Agreement For Pharmaceuticals According To § 130a Para. 8 Sgb V In The Form Of An Open House Model For The Active Ingredient Alfacalcidol (atc Code According To Who 2026-06-13
Germany Contract For Special Provision According To § 140a Sgb V For The Treatment Of Patients Using Intravitreal Drug Administration Of Vegf Inhibitors (ivi) In Schleswig-holstein And Hamburg 2026-06-13
Whats app